ABSTRACT. Various studies have demonstrated pronounced systemic IgG response to Pseudomonas aevuginosa (PA) infection in cystic fibrosis (CF). However, antibody response to serotype-specific lipopolysaccharides (LPS) has never been studied. ELISA for detection of IgG antibodies to L P S of nine PA-serotypes and to toxin A were performed with serum of 78 C F patients. Anti-LPS profiles of antibodies were confirmed by SDS-PAGE and immunoblotting techniques. The most frequent PA-serotypes found were immunotypes (IT) IT-1 and IT-2, and Habs-3 and Habs-4. Ten patients without PA colonization showed no detectable antibody titers. In patients with chronic PA colonization (n = 46), these antibody titers were significantly (p < 0.005) higher than in patients with intermittent PA colonization (n = 22). Mean serum antibody titers to L P S of PA IT-1, IT-2, Habs-3, and Habs-4 correlated with duration of PA colonization and with disease severity. Subclass analysis of anti-LPS antibodies revealed elevated levels for all four IgG subclasses and for IgA,. The IgG antibodies to L P S of PA proved to be protective in a murine burn wound sepsis model. We conclude that anti-LPS antibodies to specific P A serotypes in serum may be a sensitive measure of severity and prognosis of CF. Patients with C F show adequate functional immune response to L P S of PA, and it is possible that vaccination against PA before colonization could induce protective immunity. (Pediatv Res 27: 508-513, 1990) Abbreviations CF, cystic fibrosis IT, immunotype LPS, lipopolysaccharide PA, Pseudomonas aeruginosa Tox A. toxin A PA is a persistent sputum pathogen in most patients with advanced CF (1). Pseudomonas pulmonary infections are the major determinant of quality and duration of life in these patients. Mechanisms of virulence and pathogenesis of PA are
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CF patients infected and colonized by PA produce substantial IgG serum antibody titers against a variety of PA antigens, including exoproteins (6, 7), cell surface structures (8, 9) , outermembrane proteins (lo), water-soluble antigens (1 1, 12), and LPS (13, 14) . The majority of these antibodies against PA antigens was shown to correlate with CF disease severity and prognosis (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . These antibodies are unable to stop the spread of bacteria in the lungs and the resultant tissue destruction in advanced CF.
The purpose of our investigations was to measure antibody response to serotype-specific LPS in patients with CF and to correlate these titers with PA colonization/infection and disease stage. Moreover, we compared IgG and IgA subclass distribution of antibodies against PA from sera of CF patients and healthy individuals immunized with PA conjugate vaccine. Finally, protection against PA infection in a murine burn wound sepsis model was studied by passive transfer of IgG derived from sera of CF patients and healthy individuals immunized with PA conjugate vaccine.
MATERIALS AND METHODS
Study patients. Between January 1987 and June 1988, 78 patients with CF attending the CF clinic at our hospital were studied. There were no inclusion or exclusion criteria regarding age or disease severity, but patients were not enrolled during acute bronchopulmonary exacerbation. The patients were 1-27 y old (mean a SD, 14.7 6.2 y), 40 were female, and 38 were male. Ten patients had no PA colonization, 22 patients were classified as intermittently colonized with PA on the basis of intermittent growth of PA in sputum, and 46 patients were classified as chronically colonized on the basis of three or more positive sputum cultures over at least 1 y. Each patient was only studied once. The trial was approved by the hospital ethics committee, and the patients or their parents gave informed consent.
Serum samples were obtained by venipuncture and frozen at -20°C until tested. The patients were assigned to various categories for each of the following criteria: age, duration of PA colonization, degree of underweight, CF score, radiographic score, and vital capacity. Correlations between the categories and mean serum antibody titers were assessed graphically. Underweight was determined as percent of predicted wt for age (15) .
The CF scoring system used included physical activity, findings on physical examination and in sputum, signs of pulmonary disease, radiologic lung involvement, and gastrointestinal manifestations (15, 16) . Each of these variables was rated on a scale of 1 to 5 points, with the highest score indicating the best status. Posteroanterior and lateral chest radiographs were graded by a pediatric radiologist according to the Chrispin-Norman scoring system (17), ranging from 0 (normal chest roentgenogram) to 38 (maximal lung and chest abnormalities in CF). Vital capacity was measured in a volume-constant whole-body plethysmograph (1 8) and expressed as percentage of predicted value for ht. Vaccine studies were performed in 18 healthy volunteers of both sexes 19-45 y old. Their written informed consent was obtained according to the approval of the institutional research committee.
Purification of antigens. Tox A was purified from PA-103 as previously described (19) . LPS was extracted from cell wall fragments of the nine most frequently isolated PA-serotypes (IT-1 to IT-7 according to Fisher, and Habs-3 and Habs-4) according to methods described in detail elsewhere (20 (23). A 7.5-15% linear gradient acrylamide gel was used, and 4 pg of purified PA LPS and 2 pg of purified Tox A in SDS-sample buffer were applied per well. For immunoblot analysis, the samples were electrophoretically transferred to nitrocellulose sheets as described (24) . The sheets were incubated sequentially with serum of CF patients diluted at 1: 100 to 1:500, peroxidase-labeled, affinity-purifi goat anti-human IgG-M-A (Kirkegaard and Perry, Gaithersburg, MD), and with 4-chloro-I-naphthol substrate (Bio-Rad, Glattbrugg, Switzerland). An identical gel was used for silver staining by the method of Tsai and Frasch (25) .
IgG and IgA subclass analysis. For determination of human
IgG and IgA subclasses, an ELISA was performed as previously described (26) . The following subclass-specific murine MAb were used: anti-human IgG, (clone HP6012), anti-human IgG, (HP60 1 O), anti-human IgG4 (HP60 1 l), anti-human IgA, (BAM 12), anti-human IgA2 (M270 10) (Unipath Limited, Bedford, England), and anti-human IgG2 (HP6014) (Sigma Chemicals Co., St. Louis, MO). As a second antibody, a horseradishperoxidase conjugated goat anti-mouse IgG (Bio-Rad Laboratories, Richmond, CA) was used. After addition of substrate, the OD at 405 nm was determined as described above.
Burn wound model. The murine burn wound sepsis model of
Stieritz and Holder (27) was used with slight modification as previously described (19) . The mice (in groups of six) received 160 pg of IgG in a volume of 0.2 mL via the tail vein 24 h before the challenge with strain PA-220, S.C. injected into the burned area. During induction of burns, the animals were carefully anesthesized in an atmosphere of methoxyflurane (19) . Statistical analysis. Antibody titers are expressed as means f 1 SD. Differences between the patient groups were tested for significance by the Wilcoxon-Mann-Whitney rank sum test (28) .
RESULTS
Serum antibodies. The 10 CF patients without PA colonizationlinfection showed no detectable antibody titers to PA LPS or Tox A. The 68 CF patients with intermittent ( n = 22) or chronic ( n = 46) PA bronchopulmonary colonization/infection had elevated serum antibody titers to LPS of IT-I in 97%, to IT-2 in 69%, to Habs-3 in 74%, to Habs-4 in 7 1 %, and to Tox A in 94%, whereas antibodies to LPS of IT-3, IT-4, IT-5, IT-6, and IT-7 were found in <5%. In Figure 1 , the distribution of the two most frequently detected serum antibody titers-to LPS of IT-1 and to Tox A-are shown for the three patient groups. As listed in Table 1 , these antibody titers were significantly higher in patients chronically colonized compared to those intermittently colonized with PA.
PA cultured and isolated from sputum of six CF patients were serotyped and reflected the common types found for the serum antibody titers: Habs-4 (5x), IT-1 (3x), and Habs-3 (2x).
Graphic correlation of mean serum antibody titers with patient age, duration of PA colonization, degree of underweight, CF score, radiographic score, and vital capacity are shown in Figures  2a-f : Statistical analysis was considered inapplicable (28) .
SDS-PAGE and immunoblotting. These techniques confirmed the anti-PA LPS-specific profile of the serum antibodies measured (Fig. 3) by reaction with the 0-side chain region of LPS of IT-1, IT-2, and Habs-3.
Subclasses. The results of IgG and IgA subclass analysis of serum antibody titers to LPS of PA IT-1, to PA Tox A, and to tetanus toxin are presented in Table 2 . Pooled serum from 10 adolescent CF patients with chronic PA colonization, with similar antibody titers, and with tetanus immunization status according to recommended schedules was compared to pooled serum from 18 healthy adult volunteers before and 28 d after active immunization with PA IT-1 polysaccharide-tetanus toxoid conjugate vaccine. Anti-IT-1-LPS titers in CF patients were substantially higher for all four IgG subclasses, and also for IgA 1, compared to the vaccine response in healthy individuals. Antitetanus-toxin titers in CF patients and in unvaccinated volunteers showed similar IgG and IgA subclass distribution. Burn wound model. Table 3 shows the protection against PA infection in a murine burn wound sepsis model by passive transfer of IgG derived from sera of 10 adolescent C F patients chronically colonized with PA (with similar antibody titers to PA LPS) and from sera of 18 healthy adult volunteers before and 28 d after immunization with PA IT-1 polysaccharidetetanus toxoid conjugate vaccine. IgG antibodies isolated from CF sera were equally protective compared to those isolated from postimmunization sera, whereas IgG antibodies from preimmunization sera were only slightly more effective than control albumin, explained by preexisting specific antibodies.
DISCUSSION
Numerous studies have demonstrated an inverse correlation between serum antibody titers against a variety of relatively IgG derived from serum of:
M e a n LD50* L P S PA-220 In a murine burn wound sepsis model, we have previously demonstrated the serotype-specific protective capacity of IgG antibodies to LPS of PA isolated from rabbit hyperimmune sera (19) . In contrast, passive transfer of anti-Tox A or antielastase IgG antibodies did not significantly alter the experimental PA infection (19) . Sawada et al. (33) have confirmed these findings in the same animal model with MAb produced by mouse hybridoma cells. In this study we found that the IgG antibodies to LPS of PA derived from CF sera were as protective as those derived from postimmunization sera of healthy controls.
In conclusion, our results indicate that anti-LPS antibodies to specific PA-serotypes in serum may be a sensitive measure of severity and prognosis of CF. Longitudinal studies are warranted to confirm this hypothesis. The role of IgG and IgA subclass distribution of antibody response to LPS of PA requires further investigation. Patients with CF show adequate functional immune response to PA with regard to IgG antibodies to LPS of PA. It is possible that vaccination against PA of CF patients who have not vet been colonized with PA could induce ~rotective immunity: Safety and immunogenicity of PA poly~accharide Tox A conjugate vaccines in humans have been satisfactorily documented (34) .
